stop_circleTerminated/Withdrawn

Endometrial hyperplasia

Mirena for the treatment of nonatypical endometrial hyperplasia for 6 months

Trial purpose

Researchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH).

Endometrial hyperplasia is a condition where the lining of the uterus (called the endometrium) becomes too thick. Nonatypical means that the condition is not cancerous. It is often caused by hormone imbalances in women. Symptoms can include abnormal vaginal bleeding or irregular periods. If this condition is not treated, then it may lead to cancer.

Currently, there are no approved treatments for NAEH and that is why there is still an unmet medical need.

The study treatment, Mirena (also known as BAY 865028), is already available as a type of birth control device. It is inserted into the uterus where it gradually releases progesterone.

In this study, researchers want to find out if Mirena works for women with NAEH. They believe it can help by keeping hormone levels balanced in the body.

The main purpose of this study is to show that uterine lining goes back to completely normal lining after treatment with Mirena and that its use is safe in this population.

For this, the researchers will compare the number of participants with benign endometrium after 6 months of treatment with Mirena or oral MPA.

The study participants will be randomly assigned into one of two treatment groups. The randomization will be done 2:1 ratio, meaning that for every two participants assigned to Mirena, one will be assigned to oral medroxyprogesterone acetate (MPA). Based on their group, participants will receive Mirena, which is inserted into the uterus at the start of the study, or they will take progestins once daily by mouth for 6 months.

Each participant will be in the study for around 10 months with up to 5 visits to the study clinic/site.

Participants will visit the study clinic:
- once before the treatment starts
- 3 times with a gap of 3 months between the visits during the treatment
- then 1 more time after the treatment ends

During the study, the doctors and their study team will:
- check participant's health by performing tests such as blood and urine tests
- perform vaginal ultrasound and hysteroscopy. Hysteroscopy is a minor surgical procedure where a thin camera will be inserted into the womb to check for any abnormality. Sampling of the endometrial lining (cells in the womb) will be done with a thin tube at the same time.
- take samples of womb (endometrial) lining
- ask the participants questions about how they are feeling and what adverse events they are having

An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment.

Key Participants Requirements

Sex

Female

Age

18 - N/A (No Limit)

Trial summary

Enrollment Goal
0
Trial Dates
November 2025 - June 2026
Phase
Phase III
Could I Receive a placebo
No
Products
Levonorgestrel, BAY 865028
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Cornerstone Clinic for Women – AldersgateLittle Rock, 72205, United States
Active, not recruiting
Lyndhurst Clinical ResearchWinston Salem, 27103, United States
Active, not recruiting
AIH Research- BroadwayPearland, 77584, United States
Active, not recruiting
Discovery Clinical Trials - DallasDallas, 75230, United States
Active, not recruiting
Southern Clinical Research AssociatesMetairie, 70001, United States
Active, not recruiting
ClinOhio Research Services, LLC. | Columbus, OHColumbus, 43213, United States
Active, not recruiting
Unified Women's Clinical Research - Centre OB/GYNRaleigh, 27607, United States
Active, not recruiting
Biopharma Informatic - West HoustonHouston, 77043, United States
Active, not recruiting
Bosque Women's Care | Albuquerque, NMAlbuquerque, 87109, United States
Active, not recruiting
Omni Fertility and Laser InstituteShreveport, 71118, United States
Active, not recruiting
OB/GYN Associates of ErieErie, 16507, United States
Active, not recruiting
Revive Research Institute - Michigan - Women's HealthDearborn Heights, 48127, United States
Active, not recruiting
Chattanooga Medical Research, LLC. | Chattanooga, TNChattanooga, 37412, United States
Active, not recruiting
Office of Dr. Cindy Basinski, LLCEvansville, 47715, United States
Active, not recruiting
Sweet Hope Research Specialty, Inc. - HialeahHialeah, 33016, United States
Active, not recruiting
Paramount Research Solutions | College Park LocationAtlanta, 30327, United States
Active, not recruiting
Emerald Coast Clinical ResearchPanama City, 32405, United States
Active, not recruiting
Alliance Clinical West HillsWest Hills, 91307, United States
Active, not recruiting
Velocity Clinical Research - LafayetteLafayette, 70508, United States
Active, not recruiting
Velocity Clinical Research - PhoenixPhoenix, 85006, United States
Active, not recruiting
Entrust Clinical ResearchPalmetto Bay, 33176, United States
Active, not recruiting
New Age Medical Research Corp.Miami, 33186, United States
Active, not recruiting
The Ottawa Hospital, Riverside Campus - Department of Obstetrics, Gynecology and Newborn CareOttawa, K1H 7W9, Canada
Not Yet Recruiting
Mount Sinai Hospital Toronto | GynecologyToronto, M5G 1Z5, Canada
Active, not recruiting
Centres Investigation Clinique MauricieTrois-Rivieres, G8T 7A1, Canada
Active, not recruiting
Peking Union Medical College Hospital CAMSBeijing, 100730, China
Active, not recruiting
Chongqing Maternal and Child Health Care HospitalChongqing, 401147, China
Active, not recruiting
Jiangxi Maternal and Child Health HospitalNanchang, 330006, China
Active, not recruiting
Nanjing Medical University (NMU) - The Second Affiliated HospitalNanjing, 210011, China
Active, not recruiting
Women and Children's Hospital, Qingdao University - Gynecology departmentQingdao, 266034, China
Active, not recruiting
Chengdu Women & Children's Central HospitalChengdu, 610091, China
Active, not recruiting
Xiamen Maternity and Child Health Care Hospital - Gynecology DepartmentXiamen, 361003, China
Active, not recruiting
Nanjing Maternity and Child Health Care HospitalNanjing, 210004, China
Active, not recruiting
Tangshan Maternal and Child Health Care HospitalTangshan, 063014, China
Active, not recruiting
China-Japan Friendship HospitalBeijing, 100029, China
Active, not recruiting
Shaanxi Provincial People's HospitalXi'an, 710068, China
Active, not recruiting
Peking University Shenzhen HospitalShenzhen, 518036, China
Active, not recruiting
The Third Affiliated Hospital of Southern Medical University - Gynecology DepartmentGuangzhou, 510630, China

Primary Outcome

  • Proportion of participants with Complete Resolution (CR) of NAEH
    Complete Resolution will be evaluated as benign endometrium.
    date_rangeTime Frame:
    At 6 months

Secondary Outcome

  • Recurrence of NAEH after CR
    Recurrence of NAEH on 3 months treatment free after CR at 6 months
    date_rangeTime Frame:
    At 3 months follow up after 6 months treatment
  • Progression after CR
    Endometrial hyperplasia with atypia or endometrial cancer after 3 months treatment free follow up after CR at 6 months
    date_rangeTime Frame:
    At 3 months follow up after 6 months treatment
  • Proportion of participants having hysterectomy
    date_rangeTime Frame:
    During treatment and 3 months follow up
  • Diagnosis of "benign endometrium"
    date_rangeTime Frame:
    At 6 months of treatment followed by 3 month treatment-free follow up
  • Number of participants with adverse events
    All AEs will be coded using the latest version prior to database lock of the Medical Dictionary for Regulatory Activities
    date_rangeTime Frame:
    From the signing of the informed consent form (ICF) up to 3 months after the last dose of study intervention

Trial design

A multi-center, open label, randomized parallel group study evaluating the proportion of post-menarchal women with complete response (CR) of nonatypical endometrial hyperplasia (NAEH) treated with Mirena or Oral Progestin (OP) for 6 months
Trial Type
Interventional
Intervention Type
Combination Product
Trial Purpose
Treatment
Allocation
Randomized
Blinding
Open Label
Assignment
Parallel
Trial Arms
2